BIAF has been in the news 750% more than usual
Sep 26, 2025, 6:33 PM
-44.94%
What does BIAF do
bioAffinity Technologies, based in San Antonio, Texas, focuses on non-invasive early-stage cancer diagnosis and treatment, employing 75 staff since its IPO on August 26, 2022. Its first product, CyPath Lung, aids in detecting early-stage lung cancer, enhancing patient intervention decisions.
BIAF has been in the news recently: bioAffinity Technologies Inc. (NASDAQ: BIAF) saw its shares increase following successful case studies that confirmed the effectiveness of its non-invasive lung cancer diagnostics. Additionally, the company reported a 15% increase in revenue and profits in the last quarter, attributed to strong sales and a growing customer base.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.